NO912382L - Farmasoeytiske kombinasjonspreparater som inneholder cefalosporin- og xantinderivater og deres anvendelse. - Google Patents

Farmasoeytiske kombinasjonspreparater som inneholder cefalosporin- og xantinderivater og deres anvendelse.

Info

Publication number
NO912382L
NO912382L NO91912382A NO912382A NO912382L NO 912382 L NO912382 L NO 912382L NO 91912382 A NO91912382 A NO 91912382A NO 912382 A NO912382 A NO 912382A NO 912382 L NO912382 L NO 912382L
Authority
NO
Norway
Prior art keywords
pharmaceutical combination
preparations containing
combination preparations
containing cephalosporin
xantine
Prior art date
Application number
NO91912382A
Other languages
English (en)
Norwegian (no)
Other versions
NO912382D0 (no
Inventor
Norbert Klesel
Michael Limbert
Elmar Schrinner
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO912382D0 publication Critical patent/NO912382D0/no
Publication of NO912382L publication Critical patent/NO912382L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO91912382A 1990-06-20 1991-06-19 Farmasoeytiske kombinasjonspreparater som inneholder cefalosporin- og xantinderivater og deres anvendelse. NO912382L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4019571A DE4019571A1 (de) 1990-06-20 1990-06-20 Pharmazeutische kombinationspraeparate enthaltend cephalosporin- und xanthinderivate und deren verwendung

Publications (2)

Publication Number Publication Date
NO912382D0 NO912382D0 (no) 1991-06-19
NO912382L true NO912382L (no) 1991-12-23

Family

ID=6408686

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912382A NO912382L (no) 1990-06-20 1991-06-19 Farmasoeytiske kombinasjonspreparater som inneholder cefalosporin- og xantinderivater og deres anvendelse.

Country Status (26)

Country Link
US (1) US5350753A (pt)
EP (1) EP0462506B1 (pt)
JP (1) JP3213339B2 (pt)
KR (1) KR100205161B1 (pt)
CN (1) CN1057390A (pt)
AT (1) ATE144901T1 (pt)
AU (1) AU643291B2 (pt)
BR (1) BR9102554A (pt)
CA (1) CA2044977A1 (pt)
CZ (1) CZ282285B6 (pt)
DE (2) DE4019571A1 (pt)
DK (1) DK0462506T3 (pt)
ES (1) ES2093656T3 (pt)
FI (1) FI912968A (pt)
GR (1) GR3021568T3 (pt)
HR (1) HRP940708B1 (pt)
HU (1) HU212937B (pt)
IE (1) IE76290B1 (pt)
IL (1) IL98535A (pt)
MX (1) MX26309A (pt)
NO (1) NO912382L (pt)
NZ (1) NZ238580A (pt)
PT (1) PT98028B (pt)
RU (1) RU2095063C1 (pt)
YU (1) YU48415B (pt)
ZA (1) ZA914709B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1090795A (en) 1993-11-12 1995-05-29 Cell Therapeutics, Inc. Method for preventing tissue injury from hypoxia
PT812844E (pt) 1996-06-07 2003-03-31 Hoechst Ag Utilizacao de derivados de teofilina para o tratamento e profilaxia de estados de choque novos compostos de xantina e processo para a sua preparacao
JP2006510357A (ja) * 2002-11-22 2006-03-30 ザ ジョーンズ ホプキンズ ユニバーシティ 認識障害の処置のための標的
KR101315483B1 (ko) 2011-06-23 2013-10-07 주식회사 아리바이오 항생제 및 라이소포스파티딜콜린을 포함하는 면역 증강 또는 세균성 감염 질환 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3817955A1 (de) * 1988-05-27 1989-11-30 Hoechst Ag Tnf-inhibitor enthaltendes arzneimittel

Also Published As

Publication number Publication date
DE59108321D1 (de) 1996-12-12
CS187891A3 (en) 1992-02-19
DE4019571A1 (de) 1992-01-02
CZ282285B6 (cs) 1997-06-11
JP3213339B2 (ja) 2001-10-02
HRP940708B1 (en) 1998-12-31
PT98028A (pt) 1992-03-31
HU912048D0 (en) 1991-12-30
BR9102554A (pt) 1992-01-21
FI912968A (fi) 1991-12-21
CA2044977A1 (en) 1991-12-21
IL98535A0 (en) 1992-07-15
KR100205161B1 (ko) 1999-07-01
US5350753A (en) 1994-09-27
EP0462506B1 (de) 1996-11-06
KR920000322A (ko) 1992-01-29
HU212937B (en) 1996-12-30
HUT57986A (en) 1992-01-28
FI912968A0 (fi) 1991-06-18
YU48415B (sh) 1998-07-10
EP0462506A1 (de) 1991-12-27
IE76290B1 (en) 1997-10-08
NZ238580A (en) 1993-10-26
ZA914709B (en) 1992-03-25
AU7848291A (en) 1992-01-02
IE912107A1 (en) 1992-01-01
DK0462506T3 (da) 1996-11-25
ES2093656T3 (es) 1997-01-01
HRP940708A2 (en) 1997-02-28
GR3021568T3 (en) 1997-02-28
PT98028B (pt) 1998-11-30
CN1057390A (zh) 1992-01-01
JPH04230219A (ja) 1992-08-19
RU2095063C1 (ru) 1997-11-10
YU108291A (sh) 1995-03-27
NO912382D0 (no) 1991-06-19
ATE144901T1 (de) 1996-11-15
IL98535A (en) 1996-01-19
MX26309A (es) 1994-02-28
AU643291B2 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
NO933077D0 (no) Anvendelse av il-4-reseptor for terapi i profylakse og diagnostikk av allergiske, virale og parasitiske og bakterielle sykdommer
ES2051641A1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
NO912382D0 (no) Farmasoeytiske kombinasjonspreparater som inneholder cefalosporin- og xantinderivater og deres anvendelse.
ES2101747T3 (es) Penciclovir y famciclovir y derivados de guanina relacionados para el tratamiento de infecciones por vih-1.
IL89901A (en) Strobilurine derivative
DK47988A (da) Substituerede 3-phenyl-7h-thiazolooe3,2-baaoe1,2,4aatriazin-7-oner, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter
GR3035004T3 (en) Method and composition for the treatment of herpes related disorders.
DK536986D0 (da) Cephalosporinderivater, deres fremstilling og anvendelse
DK0390066T3 (da) Cephalosporinderivater og fremgangsmåde til deres fremstilling
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.
AU4023889A (en) Pharmaceutical combination preparations and their use for the prophylaxis or treatment of bacterial infectious diseases
UA26433A (uk) Спосіб отримаhhя аміhотіазолільhих похідhих цефалоспориhу та їх солей